Introduction
The recent cyberattack on Novo Nordisk, resulting in the theft of proprietary clinical trial data, serves as a stark warning to the pharmaceutical and healthcare sectors. As we navigate 2026, the value of clinical Intellectual Property (IP) and associated patient data on the dark web has skyrocketed, making these entities prime targets for sophisticated threat actors. For defenders, this is not just a privacy issue; it is a threat to the integrity of the drug development lifecycle and patient safety. Immediate action is required to audit data access controls and implement rigorous exfiltration monitoring.
Technical Analysis
Impact: Unauthorized access and exfiltration of sensitive clinical trial data, including proprietary research and potentially Protected Health Information (PHI).
Attack Vector (Analysis): While the initial intrusion vector (e.g., specific CVE) is not detailed in the initial breach reporting, successful exfiltration of this magnitude typically involves:
- Initial Access: Likely via compromised credentials (phishing) or a third-party supply chain vendor.
- Lateral Movement: Moving from the corporate network to segmented Research & Development (R&D) environments.
- Data Staging: Aggregating data from Electronic Data Capture (EDC) systems or Clinical Trial Management Systems (CTMS).
- Exfiltration: Using encrypted channels (HTTPS, DNS tunneling) or file transfer utilities to bypass standard DLP controls.
Affected Systems:
- Clinical Trial Management Systems (CTMS)
- Electronic Data Capture (EDC) platforms
- File servers hosting trial datasets (CSV, XML, SAS formats)
Defensive Focus: Detection must pivot from simply looking for malware to hunting for behavioral anomalies related to data movement. Defenders should focus on identifying unauthorized archiving of clinical data and anomalous network egress from research endpoints.
Detection & Response
Sigma Rules
The following Sigma rules are designed to detect common behaviors associated with data staging and exfiltration in a clinical environment. These focus on the use of archiving tools in sensitive directories and mass file access.
---
title: Potential Clinical Trial Data Staging via Archiving Tools
id: 8a2b3c4d-1e2f-4a5b-8c9d-0e1f2a3b4c5d
status: experimental
description: Detects the use of archiving tools (7-Zip, WinRAR) within directories commonly used for clinical trial data storage or R&D.
references:
- https://attack.mitre.org/techniques/T1560/
author: Security Arsenal
date: 2026/04/15
tags:
- attack.collection
- attack.t1560.001
logsource:
category: process_creation
product: windows
detection:
selection_archiver:
Image|endswith:
- '\7z.exe'
- '\winrar.exe'
- '\zip.exe'
selection_cli:
CommandLine|contains:
- '-p' # Password protection often used in data theft
- '-mhe' # Encrypt headers
selection_paths:
CommandLine|contains:
- '\ClinicalTrials\'
- '\R&D\'
- '\StudyData\'
- '\Patients\'
condition: all of selection_*
falsepositives:
- Legitimate backup operations by IT staff
level: high
---
title: Suspicious High-Volume Egress from Non-Browser Applications
id: 9b3c4d5e-2f3a-5b6c-9d0e-1f2a3b4c5d6e
status: experimental
description: Detects high-volume data egress from non-standard browser applications, indicative of data exfiltration via utilities like curl or ftp.
references:
- https://attack.mitre.org/techniques/T1041/
author: Security Arsenal
date: 2026/04/15
tags:
- attack.exfiltration
- attack.t1041
logsource:
category: network_connection
product: windows
detection:
selection:
Initiated: 'true'
Image|endswith:
- '\curl.exe'
- '\wget.exe'
- '\ftp.exe'
- '\sftp.exe'
filter:
DestinationPortList:
- '80'
- '443'
filter_legit_update:
DestinationHostname|contains:
- 'microsoft.com'
- 'adobe.com'
- 'novonordisk.com'
condition: selection and not filter_legit_update
falsepositives:
- Developers using CLI tools for legitimate API calls
level: medium
KQL (Microsoft Sentinel / Defender)
This query hunts for mass access or modification of files containing clinical trial keywords within a short timeframe, a precursor to exfiltration.
DeviceFileEvents
| where Timestamp > ago(24h)
| where ActionType in ("FileCreated", "FileModified", "FileAccessed")
| where FolderPath has_any ("ClinicalTrials", "StudyData", "EDC", "SAS_Data")
| where FileName has_any (".csv", ".sas7bdat", ".xpt", ".xml", ".pdf")
| summarize count() by DeviceName, AccountName, bin(Timestamp, 5m)
| where count_ > 50 // Threshold for mass access
| project DeviceName, AccountName, TimeGenerated, Count_
| order by Count_ desc
Velociraptor VQL
This artifact hunts for processes that are reading a high number of files or reading from specific clinical folders, which may indicate data staging.
-- Hunt for processes accessing clinical trial directories
SELECT Pid, Name, Exe, Cmdline,
count(eventid) as FileAccessCount
FROM process_tracker(pt_name="ProcessTracker")
WHERE Cmdline =~ "Clinical" OR Exe =~ "Clinical"
GROUP BY Pid, Name, Exe, Cmdline
HAVING FileAccessCount > 100
Remediation Script (PowerShell)
Use this script to audit clinical directories for recently modified large files that may have been staged for exfiltration.
# Audit Clinical Trial Directories for Staged Data
$clinicalPaths = @("C:\Data\ClinicalTrials", "D:\R&D\StudyData", "\\FileServer\EDC_Share")
$thresholdHours = 24
$thresholdSizeMB = 50
$report = @()
foreach ($path in $clinicalPaths) {
if (Test-Path $path) {
Write-Host "Scanning $path..."
$files = Get-ChildItem -Path $path -Recurse -File -ErrorAction SilentlyContinue |
Where-Object { $_.LastWriteTime -gt (Get-Date).AddHours(-$thresholdHours) -and
$_.Length -gt ($thresholdSizeMB * 1MB) }
foreach ($file in $files) {
$report += [PSCustomObject]@{
FilePath = $file.FullName
SizeMB = [math]::Round(($file.Length / 1MB), 2)
LastAccess = $file.LastAccessTime
LastWrite = $file.LastWriteTime
Owner = (Get-Acl $file.FullName).Owner
}
}
}
}
if ($report.Count -gt 0) {
$report | Format-Table -AutoSize
# Alert Logic: Send email or generate SIEM event if $report is not empty
} else {
Write-Host "No large files recently modified in clinical directories."
}
Remediation
Immediate Actions:
- Isolate Affected Systems: If specific endpoints are identified as the source of exfiltration, isolate them from the network immediately to prevent further data loss.
- Revoke Credentials: Assume credential theft has occurred. Force reset passwords for all accounts with access to the compromised clinical trial datasets, particularly service accounts.
- Review Access Logs: Conduct a granular review of logs for CTMS and EDC platforms to identify the scope of data accessed (e.g., specific patient cohorts or trial phases).
Long-Term Hardening:
- Network Segmentation: Ensure R&D and clinical data environments are strictly segmented from the corporate network. Implement a "Zero Trust" architecture requiring re-authentication for lateral movement.
- Data Loss Prevention (DLP): Implement granular DLP policies specifically for clinical data formats. Fingerprinting databases containing patient data and block unauthorized uploads to web storage or personal devices.
- Vendor Risk Management: If the breach originated via a third-party partner (common in pharma supply chains), audit all remote access tunnels and enforce MFA and Just-in-Time (JIT) access for all external vendors.
Related Resources
Security Arsenal Healthcare Cybersecurity AlertMonitor Platform Book a SOC Assessment healthcare Intel Hub
Is your security operations ready?
Get a free SOC assessment or see how AlertMonitor cuts through alert noise with automated triage.